Copyright Reports & Markets. All rights reserved.

Global β Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 β Adrenoceptor Agonists Market Overview

    • 1.1 Product Overview and Scope of β Adrenoceptor Agonists
    • 1.2 Classification of β Adrenoceptor Agonists by Types
      • 1.2.1 Global β Adrenoceptor Agonists Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global β Adrenoceptor Agonists Revenue Market Share by Types in 2018
      • 1.2.3 Isoprenaline
      • 1.2.4 Dobutamine
      • 1.2.5 Salbutamol
      • 1.2.6 Terbutaline
      • 1.2.7 Salmeterol
      • 1.2.8 Formoterol
      • 1.2.9 Pirbuterol
    • 1.3 Global β Adrenoceptor Agonists Market by Application
      • 1.3.1 Global β Adrenoceptor Agonists Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Chronic Heart Failure
      • 1.3.3 Myocardial Infarction
      • 1.3.4 Postoperative Hypotension
      • 1.3.5 Bronchial Asthma
      • 1.3.6 Asthmatic Bronchitis
      • 1.3.7 Emphysema
      • 1.3.8 Others
    • 1.4 Global β Adrenoceptor Agonists Market by Regions
      • 1.4.1 Global β Adrenoceptor Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) β Adrenoceptor Agonists Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) β Adrenoceptor Agonists Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) β Adrenoceptor Agonists Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) β Adrenoceptor Agonists Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) β Adrenoceptor Agonists Status and Prospect (2014-2024)
    • 1.5 Global Market Size of β Adrenoceptor Agonists (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Ivax Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 β Adrenoceptor Agonists Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Ivax Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Physicians Total Care
      • 2.2.1 Business Overview
      • 2.2.2 β Adrenoceptor Agonists Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Physicians Total Care β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Baxter Healthcare
      • 2.3.1 Business Overview
      • 2.3.2 β Adrenoceptor Agonists Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Baxter Healthcare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sanofi
      • 2.4.1 Business Overview
      • 2.4.2 β Adrenoceptor Agonists Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sanofi β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 β Adrenoceptor Agonists Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bedford Laboratories
      • 2.6.1 Business Overview
      • 2.6.2 β Adrenoceptor Agonists Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bedford Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Novartis
      • 2.7.1 Business Overview
      • 2.7.2 β Adrenoceptor Agonists Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Novartis β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Sterimax
      • 2.8.1 Business Overview
      • 2.8.2 β Adrenoceptor Agonists Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Sterimax β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Teligent
      • 2.9.1 Business Overview
      • 2.9.2 β Adrenoceptor Agonists Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Teligent β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 AstraZeneca
      • 2.10.1 Business Overview
      • 2.10.2 β Adrenoceptor Agonists Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 AstraZeneca β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Hikma Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 β Adrenoceptor Agonists Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Av Kare
      • 2.12.1 Business Overview
      • 2.12.2 β Adrenoceptor Agonists Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Av Kare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Impax Laboratories
      • 2.13.1 Business Overview
      • 2.13.2 β Adrenoceptor Agonists Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Impax Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 PD-Rx Pharmaceuticals
      • 2.14.1 Business Overview
      • 2.14.2 β Adrenoceptor Agonists Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Athenex Pharmaceutical Division
      • 2.15.1 Business Overview
      • 2.15.2 β Adrenoceptor Agonists Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Teva
      • 2.16.1 Business Overview
      • 2.16.2 β Adrenoceptor Agonists Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Teva β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Marlex Pharmaceuticals
      • 2.17.1 Business Overview
      • 2.17.2 β Adrenoceptor Agonists Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Lannett Company
      • 2.18.1 Business Overview
      • 2.18.2 β Adrenoceptor Agonists Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Lannett Company β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 West-Ward Pharmaceuticals
      • 2.19.1 Business Overview
      • 2.19.2 β Adrenoceptor Agonists Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 United Biomedical
      • 2.20.1 Business Overview
      • 2.20.2 β Adrenoceptor Agonists Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 United Biomedical β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Merck
      • 2.21.1 Business Overview
      • 2.2.2 β Adrenoceptor Agonists Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Merck β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Mylan
      • 2.22.1 Business Overview
      • 2.22.2 β Adrenoceptor Agonists Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Mylan β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)

    3 Global β Adrenoceptor Agonists Market Competition, by Players

    • 3.1 Global β Adrenoceptor Agonists Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 β Adrenoceptor Agonists Players Market Share
      • 3.2.2 Top 10 β Adrenoceptor Agonists Players Market Share
    • 3.3 Market Competition Trend

    4 Global β Adrenoceptor Agonists Market Size by Regions

    • 4.1 Global β Adrenoceptor Agonists Revenue and Market Share by Regions
    • 4.2 North America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 4.3 Europe β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 4.5 South America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    5 North America β Adrenoceptor Agonists Revenue by Countries

    • 5.1 North America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
    • 5.2 USA β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 5.3 Canada β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    6 Europe β Adrenoceptor Agonists Revenue by Countries

    • 6.1 Europe β Adrenoceptor Agonists Revenue by Countries (2014-2019)
    • 6.2 Germany β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 6.3 UK β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 6.4 France β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 6.5 Russia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 6.6 Italy β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific β Adrenoceptor Agonists Revenue by Countries

    • 7.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Countries (2014-2019)
    • 7.2 China β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 7.3 Japan β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 7.4 Korea β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 7.5 India β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    8 South America β Adrenoceptor Agonists Revenue by Countries

    • 8.1 South America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
    • 8.2 Brazil β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue β Adrenoceptor Agonists by Countries

    • 9.1 Middle East and Africa β Adrenoceptor Agonists Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 9.3 UAE β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)

    10 Global β Adrenoceptor Agonists Market Segment by Type

    • 10.1 Global β Adrenoceptor Agonists Revenue and Market Share by Type (2014-2019)
    • 10.2 Global β Adrenoceptor Agonists Market Forecast by Type (2019-2024)
    • 10.3 Isoprenaline Revenue Growth Rate (2014-2024)
    • 10.4 Dobutamine Revenue Growth Rate (2014-2024)
    • 10.5 Salbutamol Revenue Growth Rate (2014-2024)
    • 10.6 Terbutaline Revenue Growth Rate (2014-2024)
    • 10.7 Salmeterol Revenue Growth Rate (2014-2024)
    • 10.8 Formoterol Revenue Growth Rate (2014-2024)
    • 10.9 Pirbuterol Revenue Growth Rate (2014-2024)

    11 Global β Adrenoceptor Agonists Market Segment by Application

    • 11.1 Global β Adrenoceptor Agonists Revenue Market Share by Application (2014-2019)
    • 11.2 β Adrenoceptor Agonists Market Forecast by Application (2019-2024)
    • 11.3 Chronic Heart Failure Revenue Growth (2014-2019)
    • 11.4 Myocardial Infarction Revenue Growth (2014-2019)
    • 11.5 Postoperative Hypotension Revenue Growth (2014-2019)
    • 11.6 Bronchial Asthma Revenue Growth (2014-2019)
    • 11.7 Asthmatic Bronchitis Revenue Growth (2014-2019)
    • 11.8 Emphysema Revenue Growth (2014-2019)
    • 11.9 Others Revenue Growth (2014-2019)

    12 Global β Adrenoceptor Agonists Market Size Forecast (2019-2024)

    • 12.1 Global β Adrenoceptor Agonists Market Size Forecast (2019-2024)
    • 12.2 Global β Adrenoceptor Agonists Market Forecast by Regions (2019-2024)
    • 12.3 North America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
    • 12.4 Europe β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
    • 12.6 South America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of β Adrenoceptor Agonists.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the β Adrenoceptor Agonists market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the β Adrenoceptor Agonists market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Ivax Pharmaceuticals 
      Physicians Total Care
      Baxter Healthcare 
      Sanofi
      Pfizer
      Bedford Laboratories
      Novartis
      Sterimax
      Teligent
      AstraZeneca
      Hikma Pharmaceuticals
      Av Kare
      Impax Laboratories
      PD-Rx Pharmaceuticals
      Athenex Pharmaceutical Division
      Teva
      Marlex Pharmaceuticals
      Lannett Company
      West-Ward Pharmaceuticals
      United Biomedical
      Merck
      Mylan

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Isoprenaline
      Dobutamine
      Salbutamol
      Terbutaline
      Salmeterol
      Formoterol
      Pirbuterol

      Market Segment by Applications, can be divided into
      Chronic Heart Failure
      Myocardial Infarction
      Postoperative Hypotension
      Bronchial Asthma
      Asthmatic Bronchitis
      Emphysema
      Others

      Buy now